NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Indian Stock Market Sees Recovery Amid Buying Interest

The benchmark indices Sensex and Nifty 50 closed marginally higher on Monday, May 18, recovering sharply from the day's lows amid buying interest in select heavyweight stocks. The Sensex, which had plunged over 1,000 points intraday, rebounded more than 1,100 points to finish in positive territory. Similarly, the Nifty 50 hit an intraday low of 23,317 before recovering over 300 points from the day's bottom.

Market Performance

IndexPrevious CloseCurrent CloseChange
Sensex-75,315.04+77 points (0.10%)
Nifty 50-23,649.95+6 points (0.03%)

The 30-share Sensex ended 77 points, or 0.10%, higher at 75,315.04, while the Nifty 50 edged up 6 points, or 0.03%, to settle at 23,649.95. The market is likely to continue its gaining streak as trends in the Gift Nifty index signaled a positive opening on Tuesday. Gift Nifty was trading near the 23,649 mark, up over 31.50 points from the previous close of Nifty futures.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Indian equity markets are likely to begin today's session on a positive note, with Gift Nifty trading near the 23,708 zone compared to yesterday's Nifty close of 23,649. Supportive global cues and easing geopolitical fears are helping improve early market sentiment after recent volatility-driven sessions.

Several stocks are likely to remain in focus on Tuesday due to their own positive/negative triggers. Shares of Bharat Electronics, Bharat Petroleum Corporation, Mankind Pharma, and Zydus Lifesciences will remain in focus as companies will declare Q4 results today.

Other notable developments include:

  • Lupin securing tentative approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Revefenacin Inhalation Solution, available in 175 mcg/3 mL unit-dose vials.
  • Indian Oil Corporation posting a 56.6% year-on-year (YoY) rise in net profit to ₹11,377.51 crore, up from ₹7,264.85 crore in the same period last year, driven by strong marketing and refining margins.
  • Eicher Motors announcing that the Andhra Pradesh government has approved the allotment of a 215.7-acre land parcel in Tada for its proposed greenfield manufacturing expansion project, which is expected to involve an investment of up to ₹2,500 crore.
  • Adani Group firms are likely to remain in focus after the US Department of Justice withdrew all criminal charges against billionaire Gautam Adani and his nephew Sagar Adani, bringing the high-profile securities and wire fraud case in New York to a close after prosecutors determined the allegations were no longer tenable.
  • Astral posting a mixed performance for the March quarter, as both profit and revenue recorded strong year-on-year growth, but fell short of Street estimates on key operational parameters.
  • Afcons Infrastructure reporting a consolidated net loss of ₹88.4 crore for the quarter ended March 2026, against a net profit of ₹110.9 crore in the corresponding period last year, due to macroeconomic challenges and certain one-off factors.
  • Apollo Micro Systems posting robust earnings for the March quarter, driven by a sharp year-on-year increase in profit and revenue, aided by strong execution and better operational performance.
  • DOMS Industries posting a 17.2% YoY increase in consolidated net profit for the fourth quarter, with profit rising to ₹56.7 crore from ₹48.4 crore in the same period last year.
  • Vascon Engineers announcing that it has secured a Letter of Intent valued at ₹131.58 crore (excluding GST) from Reliance Industries for construction work related to the company's Jamnagar expansion project.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Investor Takeaway

Investors should be cautious and wait for a clear trend before making any investment decisions.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.